Indian Spices and Unhealthy Diets interfere with Drug Therapy in Diabetes and Neurodegenerative Diseases

Ian James Martins
Additional contact information
Ian James Martins: Centre of Excellence in Alzheimer’s disease Research and Care, Edith Cowan University, Australia

Novel Approaches in Drug Designing & Development, 2018, vol. 3, issue 4, 73-76

Abstract: Nutritional therapy has become important to drug metabolism and treatment with the calorie sensitive gene Sirtuin 1 (Sirt 1) shown to be critical to the prevention of non alcoholic fatty liver disease (NAFLD) with the activation of hepatic drug metabolism. Indian spices have been used extensively in healthy diets in the developing and developed countries for the prevention of NAFLD, diabetes and Alzheimer’s disease. Experimental evidence with relevance to ingestion of Indian spices (mg/day) is limited in various countries. Curcumin intake (mg/day) an amyloid beta aggregation inhibitor for the treatment of Alzheimer’s disease should be carefully controlled to prevent mitophagy and NAFLD. Indian spices that contain Sirt 1 activators such as cinnamon should be consumed to maintain hepatic drug and spice metabolism with the prevention of insulin resistance. Excessive intake of various Indian spices should be avoided to maintain the therapeutic properties of curcumin and cinnamon and to prevent spice-drug or drug-drug interactions. Data on safety and toxicity of Indian spices may indicate that toxic curcumin effects may be related to over ingestion of various Indian spices relevant to drug induced mitochondrial toxicity in NAFLD, diabetes and neurodegenerative diseases.

Keywords: juniper publishers; drug designing pdf; drug designing articles; drug designing abstract; drug designing journal; modern approaches in drug designing journal; drug designing & intellectual properties international journal; peer reviewed open access journals; high impact journals; juniper publishers review (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/napdd/pdf/NAPDD.MS.ID.555616.pdf (application/pdf)
https://juniperpublishers.com/napdd/NAPDD.MS.ID.555616.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jnapdd:v:3:y:2018:i:4:p:73-76

DOI: 10.19080/NAPDD.2018.03.555616

Access Statistics for this article

Novel Approaches in Drug Designing & Development is currently edited by Sophia Mathis

More articles in Novel Approaches in Drug Designing & Development from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().